Peripheral and central venous catheters (PVC and CVC, respectively) are often used for hospitalized patients. They pose a risk of infection both as a foreign body and due to potential damage to the skin barrier. However, there is still little data on the frequency of use and infections in Germany. The aim of this study was to use a point-prevalence analysis (PPA) to determine the prevalence of associated infections and possible risk factors due to the use of CVCs and PVCs.
Acknowledgments
Translated from the original German by Veronica A. Raker, PhD.
Footnotes
Conflict of interest statement
The authors declare that no conflict of interest exists.
Methods
A PPA was carried out at 78 intensive care hospitals of the Helios Group in May 2019. Basic to maximum care providers were represented in a ratio that is comparable to the overall distribution of hospitals in Germany. Hygiene specialists visited all stations in an unannounced manner and recorded all PVCs and CVCs present, including tunneled catheters and ports. Patients were examined for signs of infection, such as redness, pain, or thrombophlebitis. If transparent dressing had not been used, the dressing was removed for inspection. Patient files were searched to determine if vascular catheter–associated bacteremia had been detected within the previous three days. For indwelling PVCs, the indication was also questioned; PVCs that had not been used in the last 24 h, and for which no intravenous therapy was planned in the next 24 h, were classified as catheters kept in place without indication.
Results
Eight hundred wards were visited (including 78 intensive or intermediate care wards and 10 neonatal intensive care wards). Overall, 39.5% of patients had at least one vascular catheter. For 1 574 of the catheters (21.7% of all placed catheters with corresponding documentation, 95% CI: [20.8; 22.7]), the last inspection had taken place more than 2 days previously. The catheter that had been left unused for the longest period of time was a PVC that had been placed 19 days previously but had not been used for the past 18 days, and it showed clear signs of inflammation. Of the indwelling PVCs, 678 (9.4% [8.8; 10.1]) had no clear indication. Overall, 251 catheter sites (3.1%, [2.7; 3.5]) showed signs of infection. At the time of the PPA, 1.4% [1.3; 1,6] of the catheters in the hospitalized patients were associated with a nosocomial infection. In most cases (97% of infected catheters), only local signs of inflammation were observed (table 1).
Table 1. Results of the point-prevalence analysis of N = 17 586 observed patients*1.
Number (percentage) | |
Patients with at least one vascular catheter | N = 6947 (39.5%) |
Male | N = 3598 (51.4%) |
Age (years), Md (Q25 – Q75) | 71 (58–81) |
Patients with > 1 catheter | N = 1157 |
Vascular catheters, total | N = 8104 |
Use rate*2 | 8104/17 586 (46.1%) |
PVC | 7181/17 586 (40.1%) |
CVC | 923/17 586 (5.3%) |
Entry site PVC | |
– Back of hand | 2706 (37.7%) |
– Forearm | 2235 (31.1%) |
– Elbow | 2126 (29.6%) |
– Great saphenous vein | 13 (0.2%) |
– Other | 101 (1.4%) |
Entry site CVC | |
– Internal jugular vein | 729 (79.0%) |
– Femoral vein | 59 (6.4%) |
– Subclavian vein | 98 (10.6%) |
– Other | 37 (4.0%) |
Dressing unclean or loose | 1 282 (15.6%) |
Duration of use, PVC (N = 6 007), days Md (Q25–Q75) |
(1 – 3) |
Duration of use, CVC (N = 855), days Md (Q25–Q75) |
4 (2 – 7) |
Last use, PVC (N = 6 611), hours Md (Q25–Q75) |
1 (0 – 6) |
Last use, CVC (N = 922), hours Md (Q25–Q75) |
0 (0–0) |
Placement date documented in patient chart | 6043 (74.6%) |
Last documented inspection (N = 7 244); days Mw ± SD (min–max) |
1.11 ± 2.6 (0 – 91) |
Catheter-associated infection (per 1 000 VC) – Local signs of inflammation (per 1 000 VC) – Thrombophlebitis (per 1 000 VC) – Bacteremia (per 1 000 VC) PP of infection of PVCs (per 1 000) PP of infection of C VCs (per 1 000) |
251/8 104 (= 31) 243 (29.9) 7 (0.86) 1 (0.12) 220/7 181 (30.6) 31/923 (33.5) |
*1 The median age of 6 947 patients with vascular catheter was 71 years (range 0 – 103).
*2 The rate of use for vascular catheters was defined as the quotient of the number of vascular catheters and the number of inpatients.
CVC, central venous catheters; max, maximum; Md, median; min, minimum; Mw, mean; PVC, peripheral venous catheters; Q25, 25% quartiles; Q75, 75% quartiles; SD, standard deviation; VC, vascular catheters
In the multivariate logistic regression analysis, unclean dressings and no recent inspection were identified as independent risk factors for an infection of a PVC (table 2).
Table 2. Risk factors for peripheral venous catheter infection*.
Variable | Odds ratio | [95% CI] | p-values |
Use of check valves | 1.034 | [0.699; 1.556] | 0.838 |
Use of extensions | 0.731 | [0.353; 1.518] | 0.401 |
Unclean dressing | 3.413 | [2.342; 4.973] | < 0.001 |
Placement documented | 1.093 | [0.698; 1.712] | 0.697 |
Use duration per day | 1.024 | [0.953; 1.100] | 0.522 |
Last documented inspection > 48 h | 1.611 | [1.067; 2.432] | 0.023 |
Inserted without appropriateindication | 1.168 | [0.682; 2.00] | 0.572 |
* Multivariate, logistic regression analysis showing the odds ratio and 95% confidence intervals [95% CI] for the respective factors.
Only patients with one insertion site for whom complete data were available were included (N = 4 493).
Discussion
More than 17 000 patients were examined. On average, every third patient had at least one PCV/CVC. Around 3% of all catheters showed signs of infection at the time of the PPA. Most cases (97%) presented local inflammation. Similar high prevalence rates of infection have been described in other studies (1).
Some risk factors for the infection of vascular catheters are known and are now taken into account in standards. Placing CVCs with maximum barrier measures, using skin antisepsis with an antiseptic active ingredient, and positioning the PVCs preferably on the back of the hand or forearm are established in standards. The aim of this study was to identify risk factors that have not previously been the focus of studies. Catheter-specific risk factors for the development of an infection in PVCs were unclean dressings and no recent inspection. The entry site and the dressing should be inspected daily (2) to ensure a safe dressing and to detect infections at an early stage. In addition, inspections serve as reminders to review the indication. In our investigation, almost a quarter of all vascular catheters had not been inspected for at least two days, 16% of all dressings were not acceptable, and 9% of all catheters had no clear indication. In previous prevalence studies, the proportion of unused catheters was reported to range from 7% to 38% (1, 3). In many clinics, PVCs are placed in the emergency room by nurses before examination of the patient or prescription of intravenous medication by the physician. Often these catheters are not used later and are only left in place to extract blood or as a prophylactic because the patient‘s condition could worsen.
Indwelling duration is one of the known risk factors for infection of vascular catheters. Changing the catheter at certain time intervals does not prevent infection (4). Presumably, it is not the indwelling duration per se but rather the total exposure to vascular catheters that poses a risk for infection. Reducing exposure by removing unnecessary catheters as early as possible leads to a reduction in infections. Simple measures as reminders can be very effective (5). One limitation of this non-confirmatory observational study is that, despite the large sample from a wide range of clinics, it cannot be guaranteed that the results are representative.
In sum, we found a high prevalence of vascular catheters among inpatients. Some catheters were infected, but not severely in the majority of cases. Risk factors for an infection were primarily those that indicated a lack of awareness of the problem logistics. By implementing suitable training measures as well as stringent guidelines for indication, documentation, and care, infections could be reduced.
References
- 1.Ritchie S, Jowitt D, Roberts S Service ADHBIC. The Auckland City Hospital Device Point Prevalence Survey 2005: utilisation and infectious complications of intravascular and urinary devices. N Z Med. 2007;120 U2683. [PubMed] [Google Scholar]
- 2.KRINKO. Prävention von Infektionen, die von Gefäßkathetern ausgehen. Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsblatt. 2017;2 [Google Scholar]
- 3.McHugh SM, Corrigan MA, Dimitrov BD, et al. Role of patient awareness in prevention of peripheral vascular catheter-related bloodstream infection. Infect Control Hosp Epidemiol. 2011;32:95–96. doi: 10.1086/657630. [DOI] [PubMed] [Google Scholar]
- 4.Webster J, Osborne S, Rickard CM, Marsh N. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 doi: 10.1002/14651858.CD007798.pub5. CD007798. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Seguin P, Laviolle B, Isslame S, Coué A, Mallédant Y. Effectiveness of simple daily sensitization of physicians to the duration of central venous and urinary tract catheterization. Intensive Care Med. 2010;36:1202–1206. doi: 10.1007/s00134-010-1829-1. [DOI] [PubMed] [Google Scholar]